HI. Agree (and thanks for highlighting the details).
All pieces of the Puzzle.
Showing results in a very complicated patient population not seen otherwise is a huge achievement for them and the reputation of the product.
Ann: DurAVR First in Human Study 12 Month Results, page-17
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.87 |
Change
-0.130(1.30%) |
Mkt cap ! $208.6M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.80 | $29.54K | 3.007K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 211 | $9.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.87 | 41 | 2 |
View Market Depth
| Last trade - 13.32pm 11/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |